Enhancing Screening Practices for BE

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorRutgers, The State University of New Jersey

About this trial

Previous studies have shown that screening for Barrett's esophagus (BE), the main risk factor for esophageal adenocarcinoma, is under-utilized in the primary care setting. In fact less than 35% of eligible patients are screened despite endorsement for screening by the major GI societies in patients with risk factors. The purpose of this study is to examine current screening practices and determine if implementation of screening reminders can optimize screening practices for Barrett's Esophagus within a large, academic based healthcare system in NJ.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

18 years of age or older

Have a scheduled appointment with a participating provider

Disqualifiers

Less than 18 years of age

Trial design

Design model

Parallel

Treatments tested in this trial

  • Screening Reminder

    Other intervention

    A reminder to screen this patient for Barrett's esophagus (BE) will be sent to the provider before the patient's scheduled appointment. The reminder will provide details about which criteria this patient meets in order to indicate that BE screening should be initiated.

Treatment groups

3,000 Participants
are divided into 2 treatment groups
Group A: Standard of CareNo intervention 0 interventions
Group B: InterventionActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

BE screening rate

Percentage increase in BE screening compared to each arm's historical control BE screening rate from the year prior.

Time frame
1 year

Secondary outcomes

Other outcomes

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: